Founders

G-Q-Daley.png

George Daley, M.D., Ph.D.

Dean of the Faculty of Medicine and Professor of Medicine, Biological Chemistry and Molecular Pharmacology, Harvard Medical School

Richard.jpg

Richard Gregory, Ph.D.

Professor of Biological Chemistry and Molecular Pharmacology, and Pediatrics, Harvard Medical School, Co-Director, HMS Initiative for RNA Medicine

Frank-Slack.jpg

Frank Slack, Ph.D.

Professor of Pathology, Harvard Medical School, Professor of Pathology and Director of Institute of RNA Medicine, Beth Israel Deaconess Medical Center

Piotr_Sliz

Piotr Sliz, Ph.D.

Associate Professor of Pediatrics and of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Director of Research Information, Boston Children’s

 

Management Team

Kazumi.jpg

Kazumi Shiosaki, Ph.D.

President and Chief Executive Officer

Managing Director, MPM Capital

Founder and CEO, Mitobridge

Epizyme (founder), Millennium, Abbott

Shomir Ghosh pic2.png

Shomir Ghosh, Ph.D.

Chief Scientific Officer

CSO at IFM Therapeutics

EIR, Atlas Venture

Tempero Pharmaceuticals (a GSK company), Millennium, Abbott, Parke-Davis

Ross.jpg

Ross Stein, Ph.D.

Executive Vice President, Research

Merck, ProScript, Harvard Medical School, Sirtris

R_Leonard.jpg

Reid Leonard, Ph.D.

Acting Chief Business Officer

Potenza Therapeutics, Trieza Therapeutics, MPM, Merck

 

Board of Directors

Managing Director and co-founder, MPM Capital

Luke Evnin, Ph.D.

Executive Partner, MPM Capital and CEO of Syndax Pharmaceuticals, Inc.

Briggs Morrison, M.D.

Principal, Vertex Ventures HC

Carolyn Ng, Ph.D.

Managing Director, Novartis Venture Fund

Michal Silverberg, M.B.A.

Vice President, Venture Investments, Johnson & Johnson Innovation – JJDC Inc.

Marian Nakada, Ph.D.  

President and CEO, Twentyeight-Seven Therapeutics

Kazumi Shiosaki, Ph.D.